Clinical Trial: Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614906) titled 'Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage' on May 22.

Brief Summary: The goal of this observational study is to understand if angiographic cerebral vasospasm (CV) can be predicted by levels of nitric oxide (NO) consumption in patients with aneurysmal subarachnoid hemorrhage (SAH). To reach this goal, the investigators will compare NO consumption levels in SAH and non-SAH patients. NO consumption levels will be analyzed from samples of participants' cerebral spinal fluid (CSF).

Study Start Date: March 03, 2024

Study Type: OBSERVATIONAL

Condition: Aneurysmal Subarachnoid Hemorrhage Cerebral Vas...